Just two months after raising $55.5 million in a private financing round, Natera (San Carlos, California) filed IPO paperwork with the SEC that could bring in as much as $100 million in an initial public offering. Natera makes DNA-based genetic tests. The company has developed its technology for prenatal testing and is also developing blood-based diagnostics for cancer. Read More
